Prevention and treatment of synucleinopathic and amyloidogenic disease

Details for Australian Patent Application No. 2005273969 (hide)

International Classifications

Event Publications

15 March 2007 PCT application entered the National Phase

PCT publication WO2006/020581 Priority application(s): WO2006/020581

13 September 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 16 Feb 2007

27 September 2007 Section 223 Application Received

Elan Pharmaceuticals, Inc.; The Regents of the University of California An application to extend the time from 22 Feb 2006 to 22 Mar 2007 in which to comply with Section 6(c) has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2006

22 November 2007 Section 223 Application Allowed

Elan Pharmaceuticals, Inc.; The Regents of the University of California The time in which to comply with Section 6(c) has been extended to 22 Mar 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

6 December 2007 Section 223(1) Allowances

Elan Pharmaceuticals, Inc.; The Regents of the University of California The time in which to comply with Section 6(c) has been extended to 24 Aug 2007

26 May 2011 Application Accepted

Published as AU-B-2005273969

22 September 2011 Standard Patent Sealed

12 January 2012 Assignment Registered

The Regents of the University of California; Elan Pharmaceuticals, Inc. The patent has been assigned to The Regents of the University of California; Neotope Biosciences Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.